| Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors KM McNeeley, E Karathanasis, AV Annapragada, RV Bellamkonda Biomaterials 30 (23-24), 3986-3995, 2009 | 154 | 2009 |
| Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications K Loomis, K McNeeley, RV Bellamkonda Soft Matter 7 (3), 839-856, 2011 | 150 | 2011 |
| Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma KM McNeeley, A Annapragada, RV Bellamkonda Nanotechnology 18 (38), 385101, 2007 | 128 | 2007 |
| Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography1 E Karathanasis, S Suryanarayanan, SR Balusu, K McNeeley, ... Radiology 250 (2), 398-406, 2009 | 111 | 2009 |
| Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers E Karathanasis, L Chan, L Karumbaiah, K McNeeley, CJ D'Orsi, ... PLoS One 4 (6), e5843, 2009 | 104 | 2009 |
| Hyperosmotic stress in murine hybridoma cells: effects on antibody transcription, translation, posttranslational processing, and the cell cycle Z Sun, R Zhou, S Liang, KM McNeeley, ST Sharfstein Biotechnology progress 20 (2), 576-589, 2004 | 52 | 2004 |
| Techniques for dual staining of DNA and intracellular immunoglobulins in murine hybridoma cells: applications to cell-cycle analysis of hyperosmotic cultures KM McNeeley, Z Sun, ST Sharfstein Cytotechnology 48, 15-26, 2005 | 5 | 2005 |
| MR trackable, chemotherapeutic nanoparticles for patient specific glioma therapy E Karathanasis, K McNeeley, A Agarwal, A Annapragada, R Bellamkonda Microscopy and Microanalysis 13 (S02), 44-45, 2007 | 4 | 2007 |
| Biomaterial strategies to modulate cancer KM McNeeley, JG Lyon, R Bellamkonda Biomaterials for cancer therapeutics, 417-444, 2013 | 3 | 2013 |
| Effect of exercise and ischemia on tissue oximetry and cytochrome in normal subjects, patients with chronic limb pain, and patients with mitochondrial mitopathies TC Chelimsky, KM Mcneeley, B Comfort, CA Piantadosi, JC LaManna Oxygen Transport to Tissue XVIII, 445-451, 1997 | 3 | 1997 |
| NI-44liposomal nanoparticles for targeting and imaging of pediatric brain tumors M Kambhampati, S Yadavilli, KM McNeeley, SB Pai, Q Yu, ... Neuro-Oncology 16 (Suppl 5), v147, 2014 | 1 | 2014 |
| HG-64 DEVELOPMENT OF IN VIVO DRUG AND GENE DELIVERY SYSTEMS TO BRAIN TUMOR USING LIPOSOMAL NANOCARRIERS M Kambhampati, J Gittens, S Yadavilli, SB Pai, KM McNeeley, OJ Becher, ... Neuro-Oncology 18 (suppl_3), iii62-iii62, 2016 | | 2016 |
| Multifunctional Nanoparticles for Personalized Medicine BT Roller, KM McNeeley, RV Bellamkonda Multifunctional Nanoparticles for Drug Delivery Applications: Imaging …, 2012 | | 2012 |
| Modulating lipsomal stealth properties to evade RES and target tumors KM McNeeley Georgia Institute of Technology, 2008 | | 2008 |
| High-throughput screening identifies microRNAs that target Nox2 and improve function following acute myocardial infarction J Yang, M Brown, H Zhang, M Martinez, Z Zhao, S Bhutani, S Yin, JJ Xi, ... | | |
| Masking and Triggered ‘Unmasking’of Targeting Ligands Improves Liposomal Delivery to Glioma K McNeeley, E Karathanasis, AV Annapragada, RV Bellamkonda | | |
| Non-Invasive Diagnosis of Intracerebral Hemorrhage Using Iodinated Liposomal Nanocarriers K McNeeley, R Bellamkonda | | |
Ravi V BellamkondaDepartment of Biology and Dept of Biomedical Engineering, Emory UniversityΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα emory.edu
